Texas
LATEST FROM BIOSPACE
The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas.
The company is now waiting for the FDA to determine a path forward in resuming clinical studies.
A look at whether the new tax reform will really spur a M&A spending spree for drugmakers.
With the J.P. Morgan Healthcare Conference now over, some analysts are looking back and picking out the “winners and losers” from the conference.
A look at whether big money and big deals will be in store for 2018.
A look at the latest startups that have emerged in 2018 so far.
Here are some thoughts on breaking into the biomechanical engineering market.
A look at some of the superstitions and rituals that scientists apply to their work.
The deal is expected to close in the first quarter of 2018.
PRESS RELEASES